Martin Tindall is an advisor at Phoenix Life Sciences. Through Phoenix Life Sciences, Martin Tindall and his colleagues plan to create a “new normal” in the medical industry: one defined not by the creation of synthetic drugs, but the purposeful utilization and delivery of natural plant materials and compounds for effective system absorption.